Business news

    ASX200 down; Universal Biosensors surge 36%; Australia gets 20m extra Pfizer doses

    Article Image
    Highlights
    • ASX200 is 0.41% lower at 6970.2 at 2pm AEST.
    • Universal Biosensors surged 36% on Lubris BioPharma agreements.
    • Australia secures additional 20 million Pfizer vaccine doses.

    The tech sector is one of a few sectors trading higher today after a strong session for technology stocks on Wall Street overnight. NextDC, Xero and Afterpay are each trading more than 1% higher.

    The Australian market is trading 0.41% lower at 6970.2 just after lunchtime today after setting a new 52-week high, as consumer staples and energy stocks weigh on the key index.

    Bitcoin continues to climb trading up 2.62% at US$58,069.39 at 2pm AEST.

    Australian-based medical technology manufacturer Universal Biosensors is skyrocketing 36% today after announcing an agreement for cancer detection technology and exclusive supply agreement with Lubris BioPharma LLC.

    Australia has secured a further 20 million doses of the Pfizer vaccine, taking the total to 40 million in 2021. Meantime NSW health authorities have temporarily paused the rollout of the AstraZeneca vaccine to all age groups.

    And Adidas? new version of its Ultraboost DNA running shoes allows customers to build the colour of the iconic logo stripes using Lego bricks as part of a new collaboration with Lego.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa